viscum tiliae- viscum album fruiting top liquid
uriel pharmacy inc - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 2 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.
viscum tiliae series 1 liquid
uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 6 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.
viscum tiliae series 2 liquid
uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - viscum album fruiting top 2 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.
viscum tiliae special series 2 liquid
uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - directions: for oral use. use: temporary relief of headache.
viscum crataegus liquid
uriel pharmacy inc. - hawthorn leaf with flower (unii: 6om09rpy36) (hawthorn leaf with flower - unii:6om09rpy36), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), equisetum arvense top (unii: 1dp6y6b65z) (equisetum arvense top - unii:1dp6y6b65z) - hawthorn leaf with flower 3 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of headache.
viscum special series c liquid
uriel pharmacy inc. - viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp) - directions: for oral use. use: temporary relief of headache.
viscum crataegus pellet
uriel pharmacy inc. - hawthorn leaf with flower (unii: 6om09rpy36) (hawthorn leaf with flower - unii:6om09rpy36), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), equisetum arvense top (unii: 1dp6y6b65z) (equisetum arvense top - unii:1dp6y6b65z) - directions: for oral use only. use: temporary relief of headache.
dofetilide capsule
greenstone llc - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide capsules are contraindicated in patients with congenital or acquired long qt syndromes. dofetilide capsules should not be used in patients wi
maprotiline hydrochloride tablet, film coated
mylan pharmaceuticals inc. - maprotiline hydrochloride (unii: 7c8j54pvfi) (maprotiline - unii:2u1w68trof) - maprotiline hydrochloride 25 mg - maprotiline hydrochloride tablets are indicated for the treatment of depressive illness in patients with depressive neurosis (dysthymic disorder) and manic depressive illness, depressed type (major depressive disorder). maprotiline is also effective for the relief of anxiety associated with depression. maprotiline hydrochloride tablets are contraindicated in patients hypersensitive to maprotiline and in patients with known or suspected seizure disorders. it should not be given concomitantly with monoamine oxidase (mao) inhibitors. a minimum of 14 days should be allowed to elapse after discontinuation of mao inhibitors before treatment with maprotiline is initiated. effects should be monitored with gradual increase in dosage until optimum response is achieved. the drug is not recommended for use during the acute phase of myocardial infarction.
dofetilide capsule
mayne pharma inc. - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - dofetilide 0.125 mg - dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide capsules can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide capsules are contraindicated in patients with congenital or acquired long qt syndromes. dofetilide capsules should not be used in pa